Abstract
Background Arterial tertiary lymphoid organs (ATLOs) are ectopic lymphoid structures that control local arterial immune responses and are characterized by germinal centers (GCs). T follicular helper cells (Tfh), resident in GCs, regulate immunoglobulin production and GC development. They consist of Tfh1, Tfh2, and Tfh17 subsets. T follicular regulatory (Tfr) cells possess suppressive functions as Tregs and migrate into GCs as Tfh cells.
Immunoglobulin G4 (IgG4)-related diseases are systemic inflammatory fibrous lesions with elevated serum IgG4 and infiltration of IgG4-positive plasmacytes. These manifest in vascular lesions as frequently formed aneurysms with prominent adventitia thickening (IgG4-related abdominal aortic aneurysm; IgG4-AAA). IgG4-AAAs contain several ATLOs. However, the association of IgG4-AAA pathogenesis and ATLOs or ATLOs and immune cell subsets is poorly understood.
Methods We performed whole-slide immunohistochemical image analysis in surgical specimens of IgG4-AAA (n = 21), non-IgG4-related inflammatory AAA (non-IgG4-IAAA, n = 17), atherosclerotic AAA (aAAA, n = 10), and Takayasu aortitis (TKA, n = 5). We examined the shape of ATLOs, the T cell subsets within and outside ATLOs, and the histological activity of IgG4-relataed disease.
Results IgG4-AAA was characterized by numerous, large, irregular-shaped ATLOs, and higher numbers of Tfr and Tfh2 cells than Tfh1 cells were present compared to patients with other vascular diseases. The morphological abnormalities (in number, area, and form) of ATLOs in IgG4-AAA and the increased number of Tfr cells are closely related to the activity of IgG4-related disease, including the number of IgG4-positive plasmacytes and the degree of adventitial thickness. All T cell subsets (Treg, Th1, Th2, and Th17) were more enriched within ATLOs than outside ATLOs. In particular, an increase in Tfr cells in IgG4-AAA was associated with ATLO formation. Increased Tfh17 cells were found in TKA, and aAAA and non-IgG4-IAAA were characterized by increased Tfh1 cells.
Conclusions In the classification of vascular lesions, considering the imbalance in T cell subsets, IgG4-AAA should be positioned as adventitial vasculitis with predominant Tfr and Tfh2 cells, accompanied by the abnormal appearance of ATLOs.
What is New?
This prospective study uses a new histopathological method for whole slide analysis. We characterized IgG4-related vascular disease according to imbalances in T cell subsets related to morphological changes of arterial/aortic tertiary lymphoid organs.
Compared to Takayasu arteritis and atherosclerotic changes, imbalances in T cell subsets—according to the predominance of follicular helper type 2 T cells and follicular regulatory T cells in IgG4-related vascular disease—suggested that IgG4-related vascular disease should be defined as adventitial vasculitis.
What are the clinical implications?
This relatively straightforward method for diagnosing vascular diseases based on imbalances in specific T cell subsets and arterial/aortic tertiary lymphoid organ changes can inform the pathological diagnosis of vasculitis, such as IgG4-related vascular disease and Takayasu arteritis.
The hallmark of an imbalance in T cell subsets can enable serological diagnosis of vasculitis and use of circulating T cells to monitor disease activity.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This study is a retrospective study.
Funding Statement
This work was supported by Grant-in Aid for Scientific Research (C) (JSPS KAKENHI) Grant Number 20K9142.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Human Investigation Review Committee of Kanazawa Medical Center (No. 30-63) and Kanazawa University Hospital (No. 973-1).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
Whole-slide image analysis was performed using QuPath's interface to the OpenSlide library
Nonstandard abbreviations and acronyms
- (IgG4-AAA)
- immunoglobulin G4-related abdominal aortic aneurysm
- (non-IgG4-IAAA)
- non-immunoglobulin G4-related inflammatory abdominal aortic aneurysm
- (ATLOs)
- arterial/aortic tertiary lymphoid organs
- (Tfh)
- follicular helper T cell
- (Th1)
- type 1 helper T cell
- (Th2)
- type 2 helper T cell
- (Th17)
- type 17 helper T cell
- (Tfh1)
- type 1 follicular helper T cell
- (Tfh2)
- type 2 follicular helper T cell
- (Tfh17)
- type 17 follicular helper T cell
- (ifTh1)
- interfollicular type 1 helper T cell
- (ifTh2)
- interfollicular type 2 helper T cell
- (ifTh17)
- interfollicular type 17 helper T cell
- (Tregs)
- regulatory T cells
- (Tfr)
- follicular regulatory T cells
- (ifTreg)
- interfollicular regulatory T cells
